An Epidemiological Study to Evaluate Standard Daily Practice in Managing Patients With Arterial Hypertension
NCT01201980 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2012-01-10
Summary
This study is aimed to evaluate response rate of the antihypertensive treatment with a calcium antagonist in real life practice, to evaluate patients' quality of life and to collect the following Serbia-specific epidemiology data on hypertension: demographic data, patents characteristics, and patients' management/treatment.
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
prof. dr Zorana Vasiljevic · Clinical Center of Serbia, Belgrade
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-12-31
- Primary Completion
- 2011-12-31
- Completion
- 2011-12-31
Countries
- Serbia
Study Locations
More Related Trials
-
Pharmaco-epidemiological Study Describing a Population of Hypertensive Patients Treated With a Fixed-dose Combination of Telmisartan and Hydrochlorothiazide
NCT02248129 ·Status: COMPLETED
-
Study Describing the Hypertensive Population Treated With Telmisartan and Conditions of Use by Medical Practitioners and Patients
NCT02242851 ·Status: COMPLETED
-
Study of Efficacy and Safety of CVAA489 in Hypertensive Patients
NCT02062645 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Valsartan/Amlodipine Combination in Patients With Severe Hypertension
NCT00171535 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Angiotensin Converting Enzyme (ACE) Inhibitors Versus Candesartan in Reducing Cardiovascular Events in Primary Treatment of Hypertension
NCT01152567 ·Status: COMPLETED
-
Azilsartan Tablets Special Drug Use Surveillance: Long-term Use
NCT02092025 ·Status: COMPLETED
-
A Clinical Study to Compare Long-term Efficacy and Safety of an Aliskiren Based Regimen to a Hydrochlorothiazidebased Treatment Regimen With Optional Addition of Amlodipine
NCT00219154 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Valsartan and Amlodipine (± HCTZ) in Adults With Moderate, Inadequately Controlled Hypertension
NCT00523744 ·Status: COMPLETED ·Phase: PHASE3
-
Double-dose Valsartan Monotherapy in Hypertension Treatment: an Effectiveness and Safety Evaluation in Chinese Patients.
NCT01541189 ·Status: COMPLETED ·Phase: PHASE4
-
An 8-week Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg in Patients With Mild-to-moderate Systolic Hypertension
NCT01281306 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness of Night Administration of Low Dose Aspirin in Hypertensive Patients
NCT01741922 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Study to Compare an Aliskiren Based Hypertensive Regimen With a Ramipril Based One Followed by a Randomized Withdrawal.
NCT00219063 ·Status: COMPLETED ·Phase: PHASE3
-
New Angiotensin II Receptor Blocker Azilsartan Study for Stronger Blood Pressure Lowering
NCT01609959 ·Status: COMPLETED ·Phase: PHASE4
-
Antihypertensive Medications and the Risk of Sepsis
NCT02248896 ·Status: COMPLETED
-
A 10-12 Week Study to Evaluate the Safety and Efficacy of 320 mg Valsartan and 80 mg Simvastatin in Combination and as Monotherapies in Treating Hypertension and Hypercholesterolemia
NCT00171093 ·Status: COMPLETED ·Phase: PHASE3
-
Dose Titration of Lisinopril in Children Aged 1 to 18 Years With Primary or Secondary Hypertension
NCT02184858 ·Status: COMPLETED ·Phase: PHASE4
-
Comparative Study of Valsartan and Amlodipine Versus Amlodipine Alone in Hypertension
NCT00333489 ·Status: COMPLETED ·Phase: PHASE4
-
Repeated Dosing Study to Assess Safety and Tolerability in CKD-3 Patients on Stable ACE-I Treatment
NCT01485900 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Valsartan vs Amlodipine and Low BP on Kidney Outcomes in Essential Hypertension
NCT06395194 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Study to Evaluate the Safety and Efficacy of the Combination of Aliskiren and Valsartan in Hypertensive Non Responders Patients
NCT00219193 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Valsartan Versus Amlodipine in Postmenopausal Women With Hypertension
NCT00171054 ·Status: COMPLETED ·Phase: PHASE4
-
A Safety and Tolerability Study of the Combination of Aliskiren/Valsartan in Patients With High Blood Pressure, Followed by Long-term Safety and Tolerability of Aliskiren, Valsartan and Hydrochlorothiazide.
NCT00386607 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Study to Evaluate Efficacy and Safety of Aliskiren (150mg & 300mg) Administered Alone and in Combo With Valsartan (160mg and 320mg) in Patients With High Blood Pressure
NCT00219180 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Efficacy and Safety of Combination Aliskiren/Amlodipine in Patients With Hypertension Not Adequately Responding to Amlodipine Alone
NCT00778921 ·Status: COMPLETED ·Phase: PHASE3
-
Antialbuminuric Effects of Valsartan and Lisinopril
NCT00171600 ·Status: TERMINATED ·Phase: PHASE4